Phreesia Inc
NYSE:PHR
Intrinsic Value
Phreesia, Inc. is a healthcare software company, which engages in the provision of patient check-in solutions for medical practices. [ Read More ]
The intrinsic value of one PHR stock under the Base Case scenario is 17.47 USD. Compared to the current market price of 23.93 USD, Phreesia Inc is Overvalued by 27%.
Valuation Backtest
Phreesia Inc
Run backtest to discover the historical profit from buying and selling PHR stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Phreesia Q4 Earnings: Growth and Profitability Focus
2024-Q4 Earnings Call
Phreesia wrapped up fiscal 2024 with a bang, seeing patient visits soar 25% to over 150 million and revenue jump 24% to $95 million. Despite an adjusted EBITDA still in the red at negative $3.5 million, it's a solid $14 million year-over-year improvement. Looking ahead, they're sticking to their fiscal 2025 forecast with revenues expected between $424 to $434 million and a spruced up adjusted EBITDA outlook now ranging from $12 million to $20 million. Driven by operational efficiencies, they anticipate at least 100 new average health care services clients in their first quarter, all while confidently planning for a profitable fiscal 2026, backed by a robust cash balance.
Balance Sheet Decomposition
Phreesia Inc
Current Assets | 195.7m |
Cash & Short-Term Investments | 87.5m |
Receivables | 92.9m |
Other Current Assets | 15.2m |
Non-Current Assets | 174.6m |
PP&E | 17.2m |
Intangibles | 153.6m |
Other Non-Current Assets | 3.9m |
Current Liabilities | 110.1m |
Accounts Payable | 8.5m |
Accrued Liabilities | 37.5m |
Other Current Liabilities | 64.1m |
Non-Current Liabilities | 8.8m |
Long-Term Debt | 5.4m |
Other Non-Current Liabilities | 3.4m |
Earnings Waterfall
Phreesia Inc
Revenue
|
356.3m
USD
|
Cost of Revenue
|
-124m
USD
|
Gross Profit
|
232.3m
USD
|
Operating Expenses
|
-368.8m
USD
|
Operating Income
|
-136.5m
USD
|
Other Expenses
|
-406k
USD
|
Net Income
|
-136.9m
USD
|
Free Cash Flow Analysis
Phreesia Inc
What is Free Cash Flow?
PHR Profitability Score
Profitability Due Diligence
Phreesia Inc's profitability score is 23/100. The higher the profitability score, the more profitable the company is.
Score
Phreesia Inc's profitability score is 23/100. The higher the profitability score, the more profitable the company is.
PHR Solvency Score
Solvency Due Diligence
Phreesia Inc's solvency score is 65/100. The higher the solvency score, the more solvent the company is.
Score
Phreesia Inc's solvency score is 65/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
PHR Price Targets Summary
Phreesia Inc
According to Wall Street analysts, the average 1-year price target for PHR is 28.94 USD with a low forecast of 17.17 USD and a high forecast of 37.8 USD.
Ownership
PHR Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Shareholder Return
PHR Price
Phreesia Inc
Average Annual Return | 14.67% |
Standard Deviation of Annual Returns | 58.94% |
Max Drawdown | -85% |
Market Capitalization | 1.3B USD |
Shares Outstanding | 56 354 600 |
Percentage of Shares Shorted | 4.53% |
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Phreesia, Inc. is a healthcare software company, which engages in the provision of patient check-in solutions for medical practices. The company is headquartered in Raleigh, North Carolina and currently employs 1,701 full-time employees. The company went IPO on 2019-07-18. The firm offers software-as-a-service (SaaS) based technology platform, namely Phreesia Platform, which offers healthcare services clients with a suite of integrated solutions that manage patient access, registration, payments and clinical support. Its platform operates as a single, unified, multi-tenant platform that has demonstrated scalability and seamless integration within the operating infrastructure of its healthcare services clients. The Company’s platform offers various solutions to its clients, which includes appointments, registration, revenue cycle, clinical support, COVID-19 product offerings, patient activation and life sciences solutions. The company serves an array of provider clients ranging from single-specialty practices, which include internal and family medicine, urology, dermatology, and orthopedics to multi-specialty groups and health systems, as well as regional and national payers and other organizations.
Contact
IPO
Employees
Officers
The intrinsic value of one PHR stock under the Base Case scenario is 17.47 USD.
Compared to the current market price of 23.93 USD, Phreesia Inc is Overvalued by 27%.